{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:10:09Z","timestamp":1746346209749,"version":"3.40.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T00:00:00Z","timestamp":1408406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s11064-014-1419-7","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T19:27:19Z","timestamp":1408390039000},"page":"2180-2188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Behavioral and Neurochemical Changes Induced by Repetitive Combined Treatments of Ketamine and Amphetamine in Mice"],"prefix":"10.1007","volume":"39","author":[{"given":"Chuan-Ching","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiang-Shu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,19]]},"reference":[{"key":"1419_CR1","doi-asserted-by":"crossref","unstructured":"Wright M (1982) Pharmacologic effects of ketamine and its use in veterinary medicine. J Am Vet Med Assoc 180:1462\u20131471","DOI":"10.2460\/javma.1982.180.12.1462"},{"key":"1419_CR2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-neuro-060909-153200","volume":"34","author":"EN Brown","year":"2011","unstructured":"Brown EN, Purdon PL, Van Dort CJ (2011) General anesthesia and altered states of arousal: a systems neuroscience analysis. Annu Rev Neurosci 34:601","journal-title":"Annu Rev Neurosci"},{"key":"1419_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","volume":"107","author":"CJ Morgan","year":"2012","unstructured":"Morgan CJ, Curran HV (2012) Ketamine use: a review. Addiction 107:27\u201338","journal-title":"Addiction"},{"key":"1419_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02791072.2000.10400244","volume":"32","author":"KL Jansen","year":"2000","unstructured":"Jansen KL (2000) A review of the nonmedical use of ketamine: use, users and consequences. J Psychoact Drugs 32:419\u2013433","journal-title":"J Psychoact Drugs"},{"key":"1419_CR5","doi-asserted-by":"crossref","unstructured":"Kalsi SS, Wood DM, Dargan PI (2011) The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J 4:7107","DOI":"10.3402\/ehtj.v4i0.7107"},{"key":"1419_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(02)00243-0","volume":"69","author":"P Dillon","year":"2003","unstructured":"Dillon P, Copeland J, Jansen K (2003) Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 69:23\u201328","journal-title":"Drug Alcohol Depend"},{"key":"1419_CR7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","volume":"62","author":"JH Krystal","year":"2005","unstructured":"Krystal JH, Perry EB, Gueorguieva R et al (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62:985\u2013995","journal-title":"Arch Gen Psychiatry"},{"key":"1419_CR8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1081\/JA-200066936","volume":"40","author":"SE Lankenau","year":"2005","unstructured":"Lankenau SE, Clatts MC (2005) Patterns of polydrug use among ketamine injectors in New York City. Subst Use Misuse 40:1381\u20131397","journal-title":"Subst Use Misuse"},{"key":"1419_CR9","first-page":"101","volume":"13","author":"C Liu","year":"2005","unstructured":"Liu C, Li J, Tsay W, Hsu J (2005) Drug use and profile of individuals arrested on drug-related charges in Taiwan. J Food Drug Anal 13:101","journal-title":"J Food Drug Anal"},{"key":"1419_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2202-7-25","volume":"7","author":"T Hayase","year":"2006","unstructured":"Hayase T, Yamamoto Y, Yamamoto K (2006) Behavioral effects of ketamine and toxic interactions with psychostimulants. BMC Neurosci 7:25","journal-title":"BMC Neurosci"},{"key":"1419_CR11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-3223(00)00976-8","volume":"48","author":"LS Kegeles","year":"2000","unstructured":"Kegeles LS, Abi-Dargham A, Zea-Ponce Y et al (2000) Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 48:627\u2013640","journal-title":"Biol Psychiatry"},{"key":"1419_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuro.2013.04.014","volume":"37","author":"C-C Lai","year":"2013","unstructured":"Lai C-C, Lee L-J, Yin H-S (2013) Combinational effects of ketamine and amphetamine on behaviors and neurotransmitter systems of mice. Neurotoxicology 37:136\u2013143","journal-title":"Neurotoxicology"},{"key":"1419_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1254\/jjp.60.25","volume":"60","author":"Y Uchihashi","year":"1992","unstructured":"Uchihashi Y, Kuribara H, Tadokoro S (1992) Assessment of the ambulation-increasing effect of ketamine by coadministration with central-acting drugs in mice. Jpn J Pharmacol 60:25\u201331","journal-title":"Jpn J Pharmacol"},{"key":"1419_CR14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-3565(25)33162-9","volume":"222","author":"C Vanderwende","year":"1982","unstructured":"Vanderwende C, Spoerlein MT, Lapollo J (1982) Cocaine potentiates ketamine-induced loss of the righting reflex and sleeping time in mice. Role of catecholamines. J Pharmacol Exp Ther 222:122\u2013125","journal-title":"J Pharmacol Exp Ther"},{"key":"1419_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.taap.2007.10.017","volume":"227","author":"J-J Ke","year":"2008","unstructured":"Ke J-J, Chen H-I, Jen CJ et al (2008) Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine. Toxicol Appl Pharmacol 227:239\u2013247","journal-title":"Toxicol Appl Pharmacol"},{"key":"1419_CR16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000127492","volume":"15","author":"D Xu","year":"2008","unstructured":"Xu D, Mo Z, Yung K et al (2008) Individual and combined effects of methamphetamine and ketamine on conditioned place preference and NR1 receptor phosphorylation in rats. Neurosignals 15:322\u2013331","journal-title":"Neurosignals"},{"key":"1419_CR17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/bja\/83.6.945","volume":"83","author":"T Kubota","year":"1999","unstructured":"Kubota T, Hirota K, Yoshida H et al (1999) Inhibitory effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats. Br J Anaesth 83:945\u2013947","journal-title":"Br J Anaesth"},{"key":"1419_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-0186(03)00104-9","volume":"44","author":"M Tso","year":"2004","unstructured":"Tso M (2004) Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices. Neurochem Int 44:1\u20137","journal-title":"Neurochem Int"},{"key":"1419_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199402000-00001","volume":"17","author":"A Hitri","year":"1994","unstructured":"Hitri A, Hurd YL, Wyatt RJ, Deutsch SI (1994) Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance. Clin Neuropharmacol 17:1\u201322","journal-title":"Clin Neuropharmacol"},{"key":"1419_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0376-8716(98)00072-6","volume":"51","author":"FJ White","year":"1998","unstructured":"White FJ, Kalivas PW (1998) Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141\u2013153","journal-title":"Drug Alcohol Depend"},{"key":"1419_CR21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ntt.2006.10.001","volume":"29","author":"H-S Yin","year":"2007","unstructured":"Yin H-S, Tan H-W (2007) Effects of amphetamine on serotoninergic and GABAergic expression of developing brain. Neurotoxicol Teratol 29:264\u2013272","journal-title":"Neurotoxicol Teratol"},{"key":"1419_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S1461145703003833","volume":"7","author":"H-S Yin","year":"2004","unstructured":"Yin H-S, Chen C-T, Lin T-Y (2004) Age- and region-dependent alterations in the GABAergic innervation in the brain of rats treated with amphetamine. Int J Neuropsychopharmacol 7:35\u201348","journal-title":"Int J Neuropsychopharmacol"},{"key":"1419_CR23","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1126\/science.1148045","volume":"318","author":"MM Behrens","year":"2007","unstructured":"Behrens MM, Ali SS, Dao DN et al (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318:1645\u20131647","journal-title":"Science"},{"key":"1419_CR24","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1523\/JNEUROSCI.2167-09.2009","volume":"29","author":"CH Liu","year":"2009","unstructured":"Liu CH, Ren JQ, Yang J et al (2009) DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains. J Neurosci 29:10663\u201310670. doi: 10.1523\/JNEUROSCI.2167-09.2009","journal-title":"J Neurosci"},{"key":"1419_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuro.2011.10.001","volume":"33","author":"H-S Yin","year":"2012","unstructured":"Yin H-S, Tien T-W, Li L et al (2012) Amphetamine differentially modifies the expression of monoaminergic and GABAergic synaptic boutons and processes in lateral habenula, dorsal and ventral hippocampal formation. Neurotoxicology 33:235\u2013245","journal-title":"Neurotoxicology"},{"key":"1419_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(79)90279-6","volume":"59","author":"R David Sturgeon","year":"1979","unstructured":"David Sturgeon R, Fessler RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotypes behavior and ataxia in rats. Eur J Pharmacol 59:169\u2013179","journal-title":"Eur J Pharmacol"},{"key":"1419_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(96)00267-1","volume":"307","author":"AH Jerram","year":"1996","unstructured":"Jerram AH, Smith PF, Darlington CL (1996) The effects of (+)-SKF10047 and ketamine hydrochloride on stereotyped behaviour, locomotor activity and ataxia in guinea pig. Eur J Pharmacol 307:269\u2013273","journal-title":"Eur J Pharmacol"},{"key":"1419_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00499718","volume":"308","author":"C Carter","year":"1979","unstructured":"Carter C, Pycock C (1979) The effects of 5,7-dihydroxytryptamine lesions of extrapyramidal and mesolimbic sites on spontaneous motor behaviour, and amphetamine-induced stereotypy. Naunyn Schmiedebergs Arch Pharmacol 308:51\u201354","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1419_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(97)00255-2","volume":"759","author":"N Lindefors","year":"1997","unstructured":"Lindefors N, Barati S, O\u2019Connor WT (1997) Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Res 759:205\u2013212","journal-title":"Brain Res"},{"key":"1419_CR30","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1073\/pnas.1100223108","volume":"108","author":"JW Middleton","year":"2011","unstructured":"Middleton JW, Kiritani T, Pedersen C et al (2011) Mice with behavioral evidence of tinnitus exhibit dorsal cochlear nucleus hyperactivity because of decreased GABAergic inhibition. Proc Natl Acad Sci 108:7601\u20137606","journal-title":"Proc Natl Acad Sci"},{"key":"1419_CR31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/syn.1114","volume":"43","author":"BW Adams","year":"2002","unstructured":"Adams BW, Bradberry CW, Moghaddam B (2002) NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. Synapse 43:12\u201318. doi: 10.1002\/syn.1114","journal-title":"Synapse"},{"key":"1419_CR32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/syn.20154","volume":"57","author":"K Kessal","year":"2005","unstructured":"Kessal K, Chessel A, Spennato G, Garcia R (2005) Ketamine and amphetamine both enhance synaptic transmission in the amygdala\u2013nucleus accumbens pathway but with different time-courses. Synapse 57:61\u201365","journal-title":"Synapse"},{"key":"1419_CR33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s002130050445","volume":"134","author":"R Kuczenski","year":"1997","unstructured":"Kuczenski R, Segal DS, Todd PK (1997) Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology 134:221\u2013229","journal-title":"Psychopharmacology"},{"key":"1419_CR34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbr.2008.03.037","volume":"191","author":"D Peleg-Raibstein","year":"2008","unstructured":"Peleg-Raibstein D, Knuesel I, Feldon J (2008) Amphetamine sensitization in rats as an animal model of schizophrenia. Behav Brain Res 191:190\u2013201","journal-title":"Behav Brain Res"},{"key":"1419_CR35","first-page":"652","volume":"54","author":"MS Dittmar","year":"2004","unstructured":"Dittmar MS, Fehm NP, Vatankhah B, Horn M (2004) Ketamine\/xylazine anesthesia for radiologic imaging of neurologically impaired rats: dose response, respiratory depression, and management of complications. Comp Med 54:652\u2013655","journal-title":"Comp Med"},{"key":"1419_CR36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0091-3057(78)90266-6","volume":"8","author":"CJ Meliska","year":"1978","unstructured":"Meliska CJ, Trevor AJ (1978) Differential effects of ketamine on schedule-controlled responding and motility. Pharmacol Biochem Behav 8:679\u2013683","journal-title":"Pharmacol Biochem Behav"},{"key":"1419_CR37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","volume":"31","author":"JE Lisman","year":"2008","unstructured":"Lisman JE, Coyle JT, Green RW et al (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31:234\u2013242","journal-title":"Trends Neurosci"},{"key":"1419_CR38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbrc.2006.10.046","volume":"351","author":"X Zhang","year":"2006","unstructured":"Zhang X, Lee TH, Xiong X et al (2006) Methamphetamine induces long-term changes in GABAA receptor \u03b12 subunit and GAD67 expression. Biochem Biophys Res Commun 351:300\u2013305","journal-title":"Biochem Biophys Res Commun"},{"key":"1419_CR39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","volume":"117","author":"D Lorrain","year":"2003","unstructured":"Lorrain D, Baccei C, Bristow L et al (2003) Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697\u2013706","journal-title":"Neuroscience"},{"key":"1419_CR40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1213\/00000539-200301000-00030","volume":"96","author":"M Masuzawa","year":"2003","unstructured":"Masuzawa M, Nakao S, Miyamoto E et al (2003) Pentobarbital inhibits ketamine-induced dopamine release in the rat nucleus accumbens: a microdialysis study. Anesth Analg 96:148\u2013152","journal-title":"Anesth Analg"},{"key":"1419_CR41","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921\u20132927","journal-title":"J Neurosci"},{"key":"1419_CR42","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","volume":"33","author":"LS Seiden","year":"1993","unstructured":"Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639\u2013676","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1419_CR43","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1471-4159.1979.tb11048.x","volume":"32","author":"N Bacopoulos","year":"1979","unstructured":"Bacopoulos N, Redmond D, Roth R (1979) Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine. J Neurochem 32:1215\u20131218","journal-title":"J Neurochem"},{"key":"1419_CR44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(97)00510-6","volume":"763","author":"M Irifune","year":"1997","unstructured":"Irifune M, Fukuda T, Nomoto M et al (1997) Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases. Brain Res 763:281\u2013284","journal-title":"Brain Res"},{"key":"1419_CR45","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.euroneuro.2007.02.005","volume":"17","author":"M Forti Di","year":"2007","unstructured":"Di Forti M, Lappin JM, Murray RM (2007) Risk factors for schizophrenia\u2014all roads lead to dopamine. Eur Neuropsychopharmacol 17:S101\u2013S107","journal-title":"Eur Neuropsychopharmacol"},{"key":"1419_CR46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03033297","volume":"6","author":"GP Reynolds","year":"2004","unstructured":"Reynolds GP, Abdul-Monim Z, Neill JC, Zhang Z-J (2004) Calcium binding protein markers of GABA deficits in schizophrenia\u2014post mortem studies and animal models. Neurotox Res 6:57\u201361","journal-title":"Neurotox Res"},{"key":"1419_CR47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0893-133X(98)00112-2","volume":"21","author":"CR Yang","year":"1999","unstructured":"Yang CR, Seamans JK, Gorelova N (1999) Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology 21:161\u2013194","journal-title":"Neuropsychopharmacology"},{"key":"1419_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","volume":"120","author":"RC Callaghan","year":"2012","unstructured":"Callaghan RC, Cunningham JK, Sykes J, Kish SJ (2012) Increased risk of Parkinson\u2019s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend 120:35\u201340","journal-title":"Drug Alcohol Depend"},{"key":"1419_CR49","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1046\/j.1460-9592.2002.00883.x","volume":"12","author":"H Hayashi","year":"2002","unstructured":"Hayashi H, Dikkes P, Soriano SG (2002) Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Pediatr Anesth 12:770\u2013774","journal-title":"Pediatr Anesth"},{"key":"1419_CR50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.283.5398.70","volume":"283","author":"C Ikonomidou","year":"1999","unstructured":"Ikonomidou C, Bosch F, Miksa M et al (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70\u201374","journal-title":"Science"},{"key":"1419_CR51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ntt.2011.01.001","volume":"33","author":"M Paule","year":"2011","unstructured":"Paule M, Li M, Allen R et al (2011) Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol 33:220\u2013230","journal-title":"Neurotoxicol Teratol"},{"key":"1419_CR52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/toxsci\/kfm084","volume":"98","author":"W Slikker","year":"2007","unstructured":"Slikker W, Zou X, Hotchkiss CE et al (2007) Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 98:145\u2013158","journal-title":"Toxicol Sci"},{"key":"1419_CR53","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","volume":"27","author":"A Becker","year":"2003","unstructured":"Becker A, Peters B, Schroeder H et al (2003) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:687\u2013700","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-014-1419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-014-1419-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-014-1419-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:55:43Z","timestamp":1746345343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-014-1419-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,19]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1007\/s11064-014-1419-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"type":"print","value":"0364-3190"},{"type":"electronic","value":"1573-6903"}],"subject":[],"published":{"date-parts":[[2014,8,19]]}}}